{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:31Z","timestamp":1794047431322,"version":"4.8.0"},"reference-count":18,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Germline HAVCR2 mutations are frequently detected in subcutaneous panniculitis-like T-cell lymphoma (SPTCL) patients with\/without hemophagocytic lymphohistiocytosis (HLH) but factors associated with variable manifestations remain undetermined. To evaluate clinical variations and associated factors in SPTCL and\/or HLH with\/without HAVCR2 mutations, we performed direct sequencing of HAVCR2 exon 2 using DNA from patients with SPTCL or idiopathic HLH\/HLH-like systemic illnesses, defined by HLH alone without secondary causes. The systematic review and individual patient data (IPD) level meta-analysis which included the present and previously published studies reporting HAVCR2 mutations in SPTCL with\/without HLH populations was subsequently conducted using random-effects meta-analysis and multivariate logistic regression. Among 34 patients enrolled, ten of 28 SPTCL patients developed HLH\/HLH-like systemic illnesses. Six cases with HAVCR2Y82C mutation manifested with HLH without panniculitis. Male sex (P=0.03) and age &lt;18 years (P=0.04) were associated with HLH, corresponding to the inverse correlation between age and HLH-2004 score (r=-0.40; P=0.02). Homozygous HAVCR2Y82C mutation was more common in the presence of HLH compared with the absence (75.0% vs. 44.4%; P=0.02). Using IPD from the present and the other three eligible cohorts (N=127), male sex, heterozygous and homozygous\/compound heterozygous HAVCR2 mutations were associated with HLH by the adjusted odds ratio of 2.93 (95% confidence interval [CI]: 1.22-7.06), 4.77 (95% CI: 1.05-21.63) and 8.48 (95% CI: 2.98-24.10), respectively. Patients with male sex and\/or germline HAVCR2 mutations showed an increased risk of developing HLH. Younger patients tended to manifest with HLH, while older patients typically presented with SPTCL with less frequent HLH\/HLH-like systemic illnesses.<\/jats:p>","DOI":"10.3324\/haematol.2022.282419","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T03:40:20Z","timestamp":1681357220000},"page":"2743-2752","source":"Crossref","is-referenced-by-count":25,"title":["Germline &lt;i&gt;HAVCR2&lt;\/i&gt; mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis"],"prefix":"10.3324","volume":"108","author":[{"given":"Chatphatai","family":"Moonla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantana","family":"Polprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcharee","family":"Komvilaisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanawat","family":"Rattanathammethee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunisa","family":"Kongkiatkamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitsada","family":"Wudhikarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirorat","family":"Kobbuaklee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitchayut","family":"Boonyabaramee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuanrat","family":"Tangcheewinsirikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samart","family":"Pakakasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piya","family":"Rujkijyanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chane","family":"Choed-Amphai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamon","family":"Phuakpet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Pongudom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udomsak","family":"Bunworasate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narittee","family":"Sukswai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darintr","family":"Sosothikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponlapat","family":"Rojnuckarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"52751","doi-asserted-by":"crossref","unstructured":"Polprasert C, Takeuchi Y, Kakiuchi N. Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma. Blood Adv. 2019; 3(4):588-595.","DOI":"10.1182\/bloodadvances.2018028340"},{"key":"52752","doi-asserted-by":"crossref","unstructured":"Gayden T, Sepulveda FE, Khuong-Quang DA. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet. 2018; 50(12):1650-1657.","DOI":"10.1038\/s41588-018-0251-4"},{"key":"52753","doi-asserted-by":"crossref","unstructured":"Koh J, Jang I, Mun S. Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. Blood Adv. 2021; 5(20):3919-3930.","DOI":"10.1182\/bloodadvances.2021004562"},{"key":"52754","doi-asserted-by":"crossref","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020; 34(4):101515.","DOI":"10.1016\/j.berh.2020.101515"},{"key":"52755","doi-asserted-by":"crossref","unstructured":"Henter JI, Horne A, Arico M. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007; 48(2):124-131.","DOI":"10.1002\/pbc.21039"},{"key":"52756","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"52757","doi-asserted-by":"crossref","unstructured":"Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted?. Stat Med. 2002; 21(11):1559-1573.","DOI":"10.1002\/sim.1187"},{"key":"52758","doi-asserted-by":"crossref","unstructured":"Chinn IK, Eckstein OS, Peckham-Gregory EC. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood. 2018; 132(1):89-100.","DOI":"10.1182\/blood-2017-11-814244"},{"key":"52759","doi-asserted-by":"crossref","unstructured":"Sonigo G, Battistella M, Beylot-Barry M. HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma. Blood. 2020; 135(13):1058-1061.","DOI":"10.1182\/blood.2019003811"},{"key":"52760","unstructured":"Cheng J, Xi L, Jang Y. Germline variants of HAVCR2 in a North American Consult Practice Cohort of subcutaneous panniculitis-like T-cell lymphoma [abstract]. Mod Pathol. 2020; 33(Suppl 2):S1266-S1267."},{"key":"52761","doi-asserted-by":"crossref","unstructured":"Wegehaupt O, Gross M, Wehr C. TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2020; 67(6):e28302.","DOI":"10.1002\/pbc.28302"},{"key":"52762","doi-asserted-by":"crossref","unstructured":"Bauman B, Pittaluga S, Zhang Y. Unusual presentation of subcutaneous panniculitis-like T cell lymphoma in patients with BENTA disease. In: Selected Abstracts from the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference. J Clin Immunol. 2021; 41(Suppl 1):S12-S13.","DOI":"10.1007\/s10875-021-01001-x"},{"key":"52763","doi-asserted-by":"crossref","unstructured":"Chaweephisal P, Sosothikul D, Polprasert C. Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with hemophagocytic lymphohistiocytosis (HLH) syndrome in children and its essential role of HAVCR2 gene mutation analysis. J Pediatr Hematol Oncol. 2021; 43(1):e80-e84.","DOI":"10.1097\/MPH.0000000000001954"},{"key":"52764","doi-asserted-by":"crossref","unstructured":"Frederiks AJ, Spagnolo DV, Ramachandran S. Subcutaneous panniculitis-like T-cell lymphoma in a 14-year-old female homozygous for HAVCR2 mutation. Australas J Dermatol. 2021; 62(4):e576-e579.","DOI":"10.1111\/ajd.13684"},{"key":"52765","doi-asserted-by":"crossref","unstructured":"LeBlanc RE, Lansigan F. Unraveling subcutaneous panniculitislike T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis. J Cutan Pathol. 2021; 48(4):572-577.","DOI":"10.1111\/cup.13863"},{"key":"52766","doi-asserted-by":"crossref","unstructured":"Sheng G, Garcia-Lloret M, Butte M. A case of subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic lymphohistiocytosis independent of germline variants in HAVCR2. In: Selected Abstracts from the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference. J Clin Immunol. 2021; 41(Suppl 1):S121.","DOI":"10.1007\/s10875-021-01001-x"},{"key":"52767","doi-asserted-by":"crossref","unstructured":"Tromp SAM, Gillissen MA, Bernelot Moens SJ. Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression. Blood Adv. 2022; 6(15):4501-4505.","DOI":"10.1182\/bloodadvances.2022007450"},{"key":"52768","unstructured":"Wells G, Shea B, O\u2019Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute. 2022."}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282419\/75532","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282419\/76104","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11052\/75532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:55Z","timestamp":1794045835000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282419","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,13]]}}}